Akorn, Inc. − Generic Pharmaceutical Files Chapter 11 with $1bn of Debt Citing "Overhang" of Terminated Merger with Fresenius Kabi AG and Related Litigation; Prepetition Lenders to Serve as Stalking Horse in Sales Process | Daily Bankrupt Company Updates Bankrupt Company News